Current through Vol. 42, No. 1, September 16, 2024
The following diseases, conditions and injuries must be
reported by physicians, laboratories, and hospitals (by infection control
practitioners, medical records personnel, and other designees) to the OSDH as
dictated in the following subsections:
(1)
Infectious diseases. Reports
of infectious diseases and conditions listed in this subsection must be
submitted electronically via secure electronic data transmission to the OSDH
within one (1) working day (Monday through Friday, state holidays excepted) of
diagnosis or positive test.
(A) Acid Fast
Bacillus (AFB) positive smear. Report only if no additional testing is
performed or subsequent testing is indicative of Mycobacterium
tuberculosis Complex.
(B)
AIDS.
(C)
Anaplasma
phagocytophilum infection.
(D) Arboviral infections (West Nile virus,
St. Louis encephalitis virus, Eastern equine encephalitis virus, Western equine
encephalitis virus, Powassan virus, California serogroup virus, chikungunya
virus, Zika virus).
(E) Brucellosis
(Brucella spp.).
(F) Campylobacteriosis
(Campylobacter spp.).
(G) Congenital rubella syndrome.
(H) Cryptosporidiosis
(Cryptosporidium spp.).
(I) Cyclosporiasis (Cyclospora
cayetanensis).
(J) Dengue
Fever.
(K)
E. coli O157,
O157:H7, or a Shiga toxin producing E. coli.
(STEC)
(L) Ehrlichiosis
(Ehrlichia spp.).
(M)
Haemophilus influenzae
invasive disease.
(N) Hantavirus
infection, without pulmonary syndrome.
(O) Hantavirus pulmonary syndrome.
(P) Hemolytic uremic syndrome,
postdiarrheal.
(Q) Hepatitis A
infection (Anti-HAV-IgM+).
(R)
Hepatitis B infection. If any of the following are positive, then all test
results on the hepatitis panel must be reported: HBsAg+, anti-HBc-IgM+, HBeAg+,
or HBV DNA+. For infants < or = 18 months, all hepatitis B related tests
ordered, regardless of test result, must be reported.
(S) Hepatitis C infection in persons having
jaundice or ALT > or = 200 with laboratory confirmation. If hepatitis C EIA
is confirmed by NAT for HCV RNA, or s/co ratio or index is predictive of a true
positive then report results of the entire hepatitis panel. For infants < or
= 18 months, all hepatitis C related tests ordered, regardless of test result,
must be reported. Positive HCV RNA are reportable by both laboratories and
providers. Negative test results for HCV RNA tests are reportable by
laboratories only.
(T) HIV.
(i) All tests indicative of HIV infection are
reportable by laboratories and providers. If any HIV test is positive, then all
HIV test results on the panel must be reported by laboratories. For infants
< or = 18 months, all HIV tests ordered, regardless of test result must be
reported.
(ii) All HIV nucleotide
sequences and negative HIV test results are only reportable by
laboratories.
(U)
Influenza-associated hospitalization or death.
(V) Legionellosis
(Legionella spp.)
(W) Leptospirosis (Leptospira
interrogans).
(X)
Listeriosis (Listeria monocytogenes).
(Y) Lyme disease (Borrelia
burgdorferi).
(Z) Malaria
(Plasmodium spp.).
(AA) Mumps.
(BB) Pertussis (Bordetella
pertussis).
(CC)
Psittacosis (Chlamydophila psittaci).
(DD) Q fever (Coxiella
burnetii).
(EE)
Rubella.
(FF) Salmonellosis
(Salmonella spp.).
(GG) SARS-CoV-2 (COVID-19).
(HH) Shigellosis (Shigella
spp.).
(II) Spotted Fever
Rickettsiosis (Rickettsia spp.) hospitalization or
death.
(JJ) Streptococcal disease,
invasive, Group A (GAS) (Streptococcus pyogenes).
(KK)
Streptococcus
pneumoniae invasive disease, in persons less than 5 years of
age.
(LL) Syphilis
(Treponema pallidum). Nontreponemal and treponemal tests are
reportable. If any syphilis test is positive, then all syphilis test results on
the panel must be reported. For infants < or = 18 months, all syphilis tests
ordered, regardless of test result, must be reported.
(MM) Tetanus (Clostridium
tetani).
(NN)
Trichinellosis (Trichinella spiralis).
(OO) Tuberculosis (Mycobacterium
tuberculosis).
(PP)
Tularemia (Francisella tularensis).
(QQ) Unusual disease syndrome.
(RR) Vibriosis (Vibrionaceae
family: Vibrio spp. (including cholera),
Grimontia spp. , Photobacterium spp.,and
other genera in the family).
(SS)
Yellow Fever.
(2)
Infectious diseases. Reports of infectious diseases and conditions
listed in this subsection must be reported to the OSDH via secure electronic
data submission within one (1) month of diagnosis or test result.
(A) CD4 cell count with corresponding CD4
cell count percentage of total (by laboratories only).
(B) Chlamydia (Chlamydia
trachomatis).
(C)
Creutzfeldt-Jakob disease.
(D)
Gonorrhea (Neisseria gonorrhoeae).
(E) HIV viral load (by laboratories
only).
(F) LGV.
Lymphogranuloma Venereum is reportable as Chlamydia and
designated as LGV.
(3)
Occupational or environmental diseases. Laboratories and
healthcare providers must report blood lead level results pursuant to the
requirements established in Title 310, Chapter 512, childhood Lead Poisoning
Prevention Rules.
(4)
Injuries.
(A) Burns.
(B) Drownings and near drownings.
(C) Traumatic brain injuries.
(D) Traumatic spinal cord injuries.
(E) Poisonings, including toxic and adverse
effects.
Amended at 9 Ok Reg 485,
eff 1-1-92 (emergency); Amended at 9 Ok Reg 1429, eff 5-1-92; Amended at 10 Ok
Reg 1997, eff 6-1-93; Amended at 11 Ok Reg 3837, eff 7-11-94; Amended at 17 Ok
Reg 2942, eff 7-13-00; Amended at 19 Ok Reg 1285, eff 5-28-02; Amended at 20 Ok
Reg 2366, eff 7-11-03; Amended at 24 Ok Reg 1978, eff 6-25-07; Amended at 26 Ok
Reg 2033, eff 6-25-09; Amended at 27 Ok Reg 2522, eff 7-25-10; Amended at 29 Ok
Reg 1601, eff 7-12-12
